11Dec 2022
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure

Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure

Among patients with new‐onset or worsening heart failure (HF) undergoing optimization of HF medical therapy, dose up‐titration of angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) therapy was associated with lower likelihood of left atrial adverse remodelling (LAAR). However, LAAR is associated with a higher risk of all‐cause mortality or hospitalization for HF. CI, confidence interval; OR, odds ratio. Among patients enrolled in BIOSTAT‐CHF, LAAR was associated with an unfavourable outcome and was prevented by ACEi/ARB up‐titration. Changes in LA dimension may be a useful marker of response to treatment and improve risk stratification in patients with HF.

  • #cardiology

Like

Save

Share